AstraZeneca showcased positive early data on three experimental weight-loss drugs at ObesityWeek, highlighting its oral GLP-1 ...

AstraZeneca is under scrutiny in China — as its top executive there and other personnel are being investigated by authorities ...

“They have very unusual symptoms: bleeding ... that authorities had received notification of the cases on Saturday. AstraZeneca said an analysis of its safety data covering reported cases ...

Cambridge: AstraZeneca has announced that Fasenra (benralizumab) has been approved in the European Union (EU) as an add-on treatment for adult patients with relapsing or refractory ...

"ATTR amyloidosis is a serious, rare disease where people experience neuropathy symptoms, such as pain ... ATTR-PN, according to AstraZeneca, is caused by a mutation in the transthyretin (TTR) gene ...

A group of clinicians and patients has called on the government at Holyrood to adopt a “Scotland-wide focus” on chronic ...

The review was initially shared yesterday in an oral and poster presentation – titled “ EQUALS: Vaginal/Sexual Health (VSH) in Patients with ER+/HER2- Metastatic Breast Cancer (mBC) ” – at the RISE UP ...

The proposed system, devised for individuals with new joint symptoms who are at a risk for RA ... Mankia received grant support from Gilead, Lilly, AstraZeneca, and Serac Life Sciences and honoraria ...

A Fierce 15 winner last year, Ventus said its drug, VENT-03, “was safe and well-tolerated at doses far exceeding those planned for use in Phase 2 trials.” The drug’s "favorable PK profile” supports ...

Following this approval, AstraZeneca has the option ... Current albuterol rescue inhalers alleviate acute symptoms, but do not treat the underlying inflammation in asthma.” ...

The origins of autoimmune diseases like it are often mysterious, and an immune system that sees the body it inhabits as an ...

Rwanda has been stepping up measures to combat Rift Valley Fever (RVF) following the country's second outbreak in two years, ...